Xinglong Zhong | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Xinglong Zhong | Cardiovascular Pharmacology | Best Researcher Award

Prof. Xinglong Zhong, Department of Cardiology, The Fourth Affiliated Hospital of Guangxi Medical University/Liuzhou Workers’ Hospital, China

Prof. Xinglong Zhong is a dedicated cardiologist specializing in the diagnosis and treatment of cardiovascular diseases, with expertise in independent coronary angiography. 🏥 His clinical practice is complemented by a strong research background, focusing on vascular aging, myocardial fibrosis, and vascular calcification. 🔬 He has co-authored multiple peer-reviewed papers in prestigious SCI-indexed journals and has accumulated 244 citations with a top paper cited 127 times. 📊 His innovative work bridges interventional cardiology and molecular research, positioning him as a rising figure in cardiovascular science and precision medicine. 🌐❤️ His efforts continue to advance heart health through scientific discovery.

Publication Profile  

Orcid

Education

Prof. Xinglong Zhong 🫀 is a skilled cardiologist specializing in the diagnosis and treatment of cardiovascular diseases, with particular expertise in independent coronary angiography. 🏥 His clinical proficiency is matched by a strong foundation in research, enabling him to bridge hands-on patient care with scientific innovation. 🔬 He has co-authored several peer-reviewed articles published in SCI-indexed journals, contributing valuable insights into vascular health and cardiology. 📚 His work exemplifies a harmonious integration of advanced interventional cardiology and active academic engagement, making him a vital contributor to both clinical excellence and medical research.

Professional Memberships

Prof. Xinglong Zhong 🩺 is currently not affiliated with any professional memberships or academic societies. While he does not hold formal memberships, his impactful research contributions and clinical expertise in cardiology speak volumes about his dedication to the field. 📚🧬 His work continues to gain recognition through high-quality publications and citation metrics, reflecting his independent commitment to advancing cardiovascular science. 🚀🔬 Despite the absence of organizational affiliations, Prof. Zhong remains a respected figure in both research and clinical communities, demonstrating that consistent innovation and scholarly excellence can shine through individual initiative and professional dedication.

Research Focus

Prof. Xinglong Zhong’s research focus lies in cardiovascular pathophysiology, with a special emphasis on vascular calcification, myocardial fibrosis, and molecular mechanisms of aging in chronic kidney disease. 🔍 His work explores the impact of gut-derived metabolites like trimethylamine-N-oxide (TMAO), inflammatory signaling pathways (NF-κB, NLRP3), and therapeutic agents such as puerarin and dihydromyricetin. 💊 He also investigates cutting-edge strategies like supramolecular hydrogels for cellular senescence and novel concepts like ion therapy in myocardial infarction. 🧪 His multidisciplinary approach bridges molecular cardiology and regenerative therapy, advancing precision treatment in heart and vascular diseases.

Publication Top Notes

  • Trimethylamine-N-oxide promotes vascular aging via inhibiting GATA4 degradation in chronic kidney disease rats
  • Enhanced fibrotic potential of COL1A1hiNR4A1low fibroblasts in ischemic heart revealed by transcriptional dynamics heterogeneity analysis at both bulk and single-cell levels
  • Lactobacillus rhamnosus GG aggravates vascular calcification in chronic kidney disease: A potential role for extracellular vesicles
  • Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling
  • Puerarin Alleviates Lipopolysaccharide-Induced Myocardial Fibrosis by Inhibiting PARP-1 to Prevent HMGB1-Mediated TLR4-NF-κB Signaling Pathway
  • Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals
  • β-Galactosidase instructed supramolecular hydrogelation for selective identification and removal of senescent cells

  • CDC42 promotes vascular calcification in chronic kidney disease

Mahshid Malakootian | Cardiovascular Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Mahshid Malakootian | Cardiovascular Pharmacology | Best Researcher Award

Assoc. Prof. Dr Mahshid Malakootian, Rajaie cardiovascular medical and research center, Iran

Born on March 21, 1981, in Tehran, Iran, Dr. Mahshid Malakootian is a distinguished molecular geneticist and Associate Professor at Rajaie Cardiovascular Medical & Research Institute, Tehran. A prolific researcher, she specializes in non-coding RNAs, cardiovascular genetics, and bioinformatics. She completed her Ph.D. in Molecular Genetics at Tarbiat Modares University and held postdoctoral fellowships at McGill University and Case Western Reserve University. Dr. Malakootian has published extensively and received numerous accolades, including Best Young Researcher awards. Fluent in English and Persian, she is a dedicated academic, head of the Cardiogenetic Research Center, and an editorial board member. 📚🧬🌍

Publication Profile

google scholar

Academic Excellence

Assoc. Prof. Dr. Mahshid Malakootian is a distinguished expert in molecular genetics and cardiogenetics, contributing significantly to the field. Since 2021, she has served as an Associate Professor at the Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Tehran, Iran. 💡 From 2018, she has led the center as its Head, advancing groundbreaking research in cardiovascular genetics. 🧬 Previously, she was an Assistant Professor from 2015 to 2021 and has been an active board member of the Research Deputy since 2015, shaping impactful scientific initiatives. 📚 Her work continues to drive innovation in cardiovascular health. ❤️

Research Experience

Assoc. Prof. Dr. Mahshid Malakootian is an accomplished molecular geneticist with extensive research experience. She pursued her post-doctorate in Experimental Medicine at McGill University, Canada (2016-2017), focusing on PCSK7 RNA regulators 🧬. Previously, she was a post-doctoral fellow at Tarbiat Modares University, Tehran (2014-2015), and a visiting research scholar at Case Western Reserve University, USA (2011-2012) 🔬. Dr. Malakootian earned her Ph.D. (2009-2014) and M.Sc. (2004-2007) in Molecular Genetics at Tarbiat Modares University, where she explored non-coding RNAs and tumorigenesis. Her academic journey began with a B.Sc. in Cellular and Molecular Sciences from the University of Tehran (1999-2003) 🧪.

Honors and Awards

Assoc. Prof. Dr. Mahshid Malakootian is an award-winning researcher recognized for her outstanding contributions in molecular genetics and stem cell technology. 🏆 She has earned accolades such as the “Best Young Researcher” award (2017, 2019) and the “Top Thesis Award” (2014). 🎖 Her pioneering research is supported by multiple grants, including studies on noncoding RNAs and cardiovascular biomarkers. She has discovered and sequenced numerous novel genetic variants, published in GenBank, and co-authored a U.S. patent for miR-her2-1, aiding breast and ovarian cancer diagnostics. 💡📚 A scholar of exceptional caliber, Dr. Malakootian remains a trailblazer in biomedical innovation. 🌟

Professional Societies

Assoc. Prof. Dr. Mahshid Malakootian is an accomplished scientist and an active member of prestigious organizations, including the American Association for Cancer Research (AACR) 🌟, the Iranian Genetics Society (IGS) 🧬, and the Iranian Biotechnology Society 🌿. Her dedication to advancing research is reflected in her role as an editorial board member of the Environmental Health Engineering and Management Journal 📚. With her extensive expertise and contributions, she continues to shape the fields of cancer research, genetics, and biotechnology, fostering innovative solutions for global health challenges 🌍. Dr. Malakootian’s work exemplifies excellence and inspires the scientific community. ✨

Teaching Experience

Associate Professor Dr. Mahshid Malakootian is a distinguished expert in molecular genetics at Shahed University, where she also leads the Advanced Molecular Genetics Lab Course 🧬. Her dedication to education and research has inspired countless students and colleagues. Dr. Malakootian has honed her expertise as a research assistant in Dr. Mowla’s laboratory, contributing to cutting-edge discoveries in molecular genetics 🔬. With a passion for advancing knowledge, she has made significant strides in her field, combining academic excellence with hands-on laboratory experience. Her work continues to shape the future of genetic research and education, making her a respected figure in the scientific community.

Research Focus

Assoc. Prof. Dr. Mahshid Malakootian focuses on cutting-edge research in microRNAs, cardiovascular diseases, and non-coding RNAs in various biological and pathological contexts. Her work explores microRNA roles in cardiovascular development, post-transcriptional regulation, and cancer biology, particularly lung and esophageal tumors. Dr. Malakootian also investigates long non-coding RNAs (lncRNAs), circular RNAs, and their interplay in genetic regulation and disease pathways. Her studies on epigenetics and innovative therapeutic approaches significantly impact cardiovascular health and cancer treatment. 🧬🩺🫀

Publication Top Notes

MicroRNAs: roles in cardiovascular development and disease

Post-transcriptional regulation of PCSK9 by miR-191, miR-222, and miR-224

Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors

Ciprofloxacin removal from aqueous media by adsorption process: a systematic review and meta-analysis

Pathophysiology, Diagnosis, Treatment, and Genetics of Carpal Tunnel Syndrome: A Review

Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma

Overexpression of BMI1, a polycomb group repressor protein, in bladder tumors: a preliminary report

Differential expression of nucleostemin, a stem cell marker, and its variants in different types of brain tumors

lncRNA PSORS1C3 is regulated by glucocorticoids and fine-tunes OCT4 expression in non-pluripotent cells